Cold agglutinin disease as a new immune-related adverse event associated with anti-PD-L1s and its treatment with rituximab. - Dutertre, Martin; de Menthon, Mathilde; Noël, Nicolas; Albiges, Laurence; Lambotte, Olivier (European Journal of Cancer, 2019)